2BB score and signals
MapLight Therapeutics, Inc.’s current 2BB score is 24 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Quality | 100 | Very Strong |
2BBBullish & Bearish
MapLight Therapeutics, Inc. (MPLT) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 24 out of 100.
MapLight Therapeutics, Inc.’s current 2BB score is 24 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Quality | 100 | Very Strong |
| Headquarters | Redwood City, California, United States |
| Founded | 2018 |
| Employees | 133 |
| 52-week range | $12.25 – $37.02 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-24 | — | -1.1261 | — | $0.00 |
| 2026-12-01 | — | -1.1954 | — | $0.00 |
| 2026-09-01 | — | -1.3552 | — | $0.00 |
| 2026-05-14 | -1.34 | -1.1153 | $0.00 | $0.00 |